Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The James Lind Alliance has supported a priority setting partnership on the surgical treatment of shoulder problems that are important to both patients and clinicians.

 

Professor of Orthopaedic Surgery and Musculoskeletal Science at NDORMS, Jonny Rees led the process which involved both patients and clinicians working together to identify what ‘Research Priorities’ in surgery for common shoulder problems should be addressed.

The aim is to ensure that those who fund health research are made aware of what matters to both patients and clinicians, leading to better evidenced based care through targeted research.

Shoulder pain and loss of shoulder function are very common in the UK, with 4% of people visiting their GP each year. With more and more patients now referred to hospital specialists for surgical treatments, it is important to know which treatments are suitable and what actions to take for a good and fast recovery.

There are also uncertainties about which operations and techniques might be best, and when such operations should be considered over conservative treatment such as physiotherapy.

Professor Jonny Rees says of the process: "Everyone involved in this JLA process found it both a challenging and rewarding experience. Our patients were brilliant and were only too pleased to be engaged in this way to help prioritise shoulder surgery research in the UK. I am very grateful to everyone that spent time helping and contributing to this very worthwhile project".

The British Elbow and Shoulder Society, and the British Orthopaedic Association funded this James Lind Alliance priority setting partnership. The partnership was also supported by and based in the Oxford Biomedical Research Unit and Oxford Biomedical Research Centre.

The partnership identified 10 Research Priorities; you can find them here.

Similar stories

Fiona Powrie honoured by British Society for Immunology

Fiona Powrie was one of four researchers from the University of Oxford recognised for their outstanding contributions to immunology with Honorary Lifetime Membership of the British Society for Immunology.

The Kennedy Institute scoops sustainability award

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

Vaccination safety: generating accurate evidence is the clearest path to creating public trust

A new study shows that a vaccine surveillance method in observational data may generate high number of false positives

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

A drug being trialled to treat cancer, could be the key to reducing gut inflammation

Published in Nature Communications, a new study reveals a new signalling pathway behind macrophage inflammatory activity

Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.